Human Gsα mutant causes pseudohypoparathyroidism type Ia/neonatal diarrhea, a potential cell-specific role of the palmitoylation cycle

Pseudohypoparathyroidism type Ia (PHP-Ia) results from the loss of one allele of Gsα, causing resistance to parathyroid hormone and other hormones that transduce signals via Gs. Most Gsαmutations cause the complete loss of protein expression, but some cause loss of function only, and these have provided valuable insights into the normal function of G proteins. Here we have analyzed a mutant Gsα (αs-AVDT) harboring AVDT amino acid repeats within its GDP/GTP binding site, which was identified in unique patients with PHP-Ia accompanied by neonatal diarrhea. Biochemical and intact cell analyses showed that αs-AVDT is unstable but constitutively active as a result of rapid GDP release and reduced GTP hydrolysis. This instability underlies the PHP-Ia phenotype. αs-AVDT is predominantly localized in the cytosol, but in rat and mouse small intestine epithelial cells (IEC-6 and DIF-12 cells) αs-AVDT was found to be localized predominantly in the membrane where adenylyl cyclase is present and constitutive increases in cAMP accumulation occur in parallel. The likely cause of this membrane localization is the inhibition of an activation-dependent decrease in αs palmitoylation. Upon the overexpression of acyl-protein thioesterase 1, however, αs-AVDT translocates from the membrane to the cytosol, and the constitutive accumulation of cAMP becomes attenuated. These results suggest that PHP-Ia results from the instability of αs-AVDT and that the accompanying neonatal diarrhea may result from its enhanced constitutive activity in the intestine. Hence, palmitoylation may control the activity and localization of Gsα in a cell-specific manner.

[1]  Yannick Marrari,et al.  Assembly and trafficking of heterotrimeric G proteins. , 2007, Biochemistry.

[2]  T. Fujita,et al.  An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations , 2007, Proceedings of the National Academy of Sciences.

[3]  A. Lania,et al.  Mechanisms of Disease: mutations of G proteins and G-protein-coupled receptors in endocrine diseases , 2006, Nature Clinical Practice Endocrinology &Metabolism.

[4]  R. Felder,et al.  Mechanisms of Disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity , 2006, Nature Clinical Practice Nephrology.

[5]  S. Hofmann,et al.  Thematic review series: Lipid Posttranslational Modifications. Lysosomal metabolism of lipid-modified proteins Published, JLR Papers in Press, April 20, 2006. , 2006, Journal of Lipid Research.

[6]  G. Hendy,et al.  Coding GNAS mutations leading to hormone resistance impair in vitro agonist- and cholera toxin-induced adenosine cyclic 3',5'-monophosphate formation mediated by human XLalphas. , 2006, Endocrinology.

[7]  R. Perdrisot,et al.  Pathophysiological roles of G-protein-coupled receptor kinases. , 2005, Cellular signalling.

[8]  T. Hynes,et al.  Live Cell Imaging of Gs and the β2-Adrenergic Receptor Demonstrates That Both αs and β1γ7 Internalize upon Stimulation and Exhibit Similar Trafficking Patterns That Differ from That of the β2-Adrenergic Receptor*[boxs] , 2004, Journal of Biological Chemistry.

[9]  Yoshiaki Ito,et al.  Runx3-/- gastric epithelial cells differentiate into intestinal type cells. , 2004, Biochemical and biophysical research communications.

[10]  R. Lefkowitz Historical review: a brief history and personal retrospective of seven-transmembrane receptors. , 2004, Trends in pharmacological sciences.

[11]  J. Smotrys,et al.  Palmitoylation of intracellular signaling proteins: regulation and function. , 2004, Annual review of biochemistry.

[12]  L. Weinstein,et al.  Inherited diseases involving g proteins and g protein-coupled receptors. , 2004, Annual review of medicine.

[13]  Anita Preininger,et al.  Insights into G protein structure, function, and regulation. , 2003, Endocrine reviews.

[14]  A. Gilman,et al.  Characterization of Saccharomyces cerevisiaeAcyl-protein Thioesterase 1, the Enzyme Responsible for G Protein α Subunit Deacylation in Vivo * , 2002, The Journal of Biological Chemistry.

[15]  S. Itohara,et al.  Causal Relationship between the Loss of RUNX3 Expression and Gastric Cancer , 2002, Cell.

[16]  M. Rasenick,et al.  Real-time visualization of a fluorescent G(alpha)(s): dissociation of the activated G protein from plasma membrane. , 2002, Molecular pharmacology.

[17]  Robert J. Lefkowitz,et al.  Seven-transmembrane-spanning receptors and heart function , 2002, Nature.

[18]  D. Manning,et al.  Regulation of G proteins by covalent modification , 2001, Oncogene.

[19]  R. Trembath,et al.  Germline mosaicism for a GNAS1 mutation and Albright hereditary osteodystrophy , 2000, Journal of medical genetics.

[20]  H. Bourne,et al.  The expanding spectrum of G protein diseases. , 1999, The New England journal of medicine.

[21]  H. Bourne,et al.  A Gsalpha mutant designed to inhibit receptor signaling through Gs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Matalon,et al.  A Novel Mutation in the Switch 3 Region of Gsα in a Patient with Albright Hereditary Osteodystrophy Impairs GDP Binding and Receptor Activation* , 1998, The Journal of Biological Chemistry.

[23]  H. Bourne,et al.  G-protein diseases furnish a model for the turn-on switch , 1998, Nature.

[24]  A. Gilman,et al.  A Cytoplasmic Acyl-Protein Thioesterase That Removes Palmitate from G Protein α Subunits and p21RAS * , 1998, The Journal of Biological Chemistry.

[25]  P. Gejman,et al.  A Novel Mutation Adjacent to the Switch III Domain of Gsα in a Patient with Pseudohypoparathyroidism , 1997 .

[26]  H. Bourne,et al.  Conditional activation defect of a human Gsalpha mutant. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Mumby Reversible palmitoylation of signaling proteins. , 1997, Current opinion in cell biology.

[28]  H. Bourne,et al.  Reciprocal regulation of Gsα by palmitate and the βγ subunit , 1996 .

[29]  H. Bourne,et al.  Pseudohypoparathyroidism, a Novel Mutation in the βγ-Contact Region of Gsα Impairs Receptor Stimulation* , 1996, The Journal of Biological Chemistry.

[30]  H. Bourne,et al.  Activation-induced subcellular redistribution of Gs alpha. , 1996, Molecular biology of the cell.

[31]  Y. Kanegae,et al.  Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Levine,et al.  A novel Gs alpha mutant in a patient with Albright hereditary osteodystrophy uncouples cell surface receptors from adenylyl cyclase. , 1994, The Journal of biological chemistry.

[33]  Paul Herzmark,et al.  Rapid GDP release from Gsα in patients with gain and loss of endocrine function , 1994, Nature.

[34]  H. Bourne,et al.  Activation and depalmitoylation of Gsα , 1994, Cell.

[35]  H. Bourne,et al.  Separate GTP binding and GTPase activating domains of a G alpha subunit. , 1993, Science.

[36]  H. Bourne,et al.  Palmitoylation is required for signaling functions and membrane attachment of Gq alpha and Gs alpha. , 1993, The Journal of biological chemistry.

[37]  H. Bourne,et al.  Activation of the alpha subunit of Gs in intact cells alters its abundance, rate of degradation, and membrane avidity , 1992, The Journal of cell biology.

[38]  E. Ross,et al.  Reconstitution of agonist-stimulated phosphatidylinositol 4,5-bisphosphate hydrolysis using purified m1 muscarinic receptor, Gq/11, and phospholipase C-beta 1. , 1992, The Journal of biological chemistry.

[39]  T. Katada,et al.  Modification of the function of pertussis toxin substrate GTP-binding protein by cholera toxin-catalyzed ADP-ribosylation. , 1992, The Journal of biological chemistry.

[40]  Frank McCormick,et al.  The GTPase superfamily: conserved structure and molecular mechanism , 1991, Nature.

[41]  T. Katada,et al.  Chemotactic peptide receptor-supported ADP-ribosylation of a pertussis toxin substrate GTP-binding protein by cholera toxin in neutrophil-type HL-60 cells. , 1989, The Journal of biological chemistry.

[42]  A. Gilman G proteins and regulation of adenylyl cyclase , 1989 .

[43]  P. Insel,et al.  Stimulation of beta-adrenergic receptors of S49 lymphoma cells redistributes the alpha subunit of the stimulatory G protein between cytosol and membranes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[44]  A. Gilman,et al.  Synthesis in Escherichia coli of GTPase-deficient mutants of Gs alpha. , 1989, The Journal of biological chemistry.

[45]  A. Gilman,et al.  Effects of Mg2+ and the beta gamma-subunit complex on the interactions of guanine nucleotides with G proteins. , 1987, The Journal of biological chemistry.

[46]  A. Gilman,et al.  The effect of GTP and Mg2+ on the GTPase activity and the fluorescent properties of Go. , 1987, The Journal of biological chemistry.

[47]  R. Happle The McCune‐Albright syndrome: a lethal gene surviving by mosaicism , 1986, Clinical genetics.

[48]  K. Isselbacher,et al.  Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria , 1979, The Journal of cell biology.

[49]  R. Deschenes,et al.  Palmitoylation: policing protein stability and traffic , 2007, Nature Reviews Molecular Cell Biology.

[50]  P. Insel,et al.  Regulation of G Protein–Coupled Receptor Signaling By Scaffold Proteins G Protein–Coupled Receptor Oligomerization: Implications for G Protein Activation and Cell Signaling Multi-Tasking RGS Proteins in the Heart: The Next Therapeutic Target? , 2005 .

[51]  J. Carel,et al.  GNAS1 lesions in pseudohypoparathyroidism Ia and Ic: genotype phenotype relationship and evidence of the maternal transmission of the hormonal resistance. , 2002, The Journal of clinical endocrinology and metabolism.